Abstract:
Non-Small Cell Lung Cancer (NSCLC) is a rare but serious condition that can affect children. This report provides an overview of NSCLC in pediatric patients, including its causes, symptoms, prevention strategies, and available medications. While NSCLC is more common in adults, understanding its occurrence in children is essential for early detection and effective treatment.
Introduction:
Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that primarily affects adults, but it can also occur in children. Although rare in pediatric patients, NSCLC necessitates attention due to its potential severity. This report aims to shed light on NSCLC in children, covering its causes, symptoms, prevention, and available medications.
Causes:
The exact causes of NSCLC in children remain largely unknown, but several risk factors have been identified:
Genetic predisposition: Children with a family history of lung cancer may be at higher risk.
Secondhand smoke exposure: Exposure to tobacco smoke, even if the child doesn't smoke, can increase the risk.
Environmental factors: Exposure to carcinogens, such as radon or asbestos, may contribute.
Pre-existing lung conditions: Children with certain lung conditions may be more susceptible.
Symptoms:
NSCLC symptoms in children can be nonspecific and may resemble other respiratory conditions. Common symptoms include:
Persistent coughing or wheezing.
Shortness of breath or labored breathing.
Chest pain.
Unexplained weight loss.
Fatigue and weakness.
Frequent respiratory infections.
Prevention:
Preventing NSCLC in children involves reducing exposure to risk factors:
Avoid secondhand smoke: Ensure a smoke-free environment for children.
Radon mitigation: Test homes for radon and take steps to reduce exposure.
Asbestos awareness: Minimize exposure to asbestos-containing materials.
Promote healthy lifestyles: Encourage a balanced diet, exercise, and good respiratory hygiene.
Medications and Treatment:
Treatment for NSCLC in children typically involves a multidisciplinary approach, which may include surgery, chemotherapy, radiation therapy, targeted therapies, and immunotherapy. Medications commonly used in pediatric NSCLC treatment include:
a. Chemotherapy drugs: Platinum-based agents, such as cisplatin or carboplatin.
b. Targeted therapies: EGFR inhibitors (e.g., erlotinib) or ALK inhibitors (e.g., crizotinib) for specific genetic mutations.
c. Immunotherapy: Immune checkpoint inhibitors like pembrolizumab or nivolumab in certain cases.
Conclusion:
Non-Small Cell Lung Cancer in children is a rare but serious condition that requires early detection and a comprehensive treatment approach. While the causes remain elusive, reducing exposure to risk factors and promoting a healthy lifestyle are key prevention strategies. Advances in medical treatments, including targeted therapies and immunotherapy, offer hope for improved outcomes in pediatric NSCLC patients. Further research is needed to better understand this condition and develop more effective treatments for children.
Citation:
(Cover image source: MD Anderson Cancer Center)
"Childhood Pleuropulmonary Blastoma Treatment (PDQ®)–Patient Version." National Cancer Institute, 15 Apr. 2021, www.cancer.gov/types/lung/patient/child-pleuropulmonary-blastoma-treatment-pdq.
De Martino, Lucia et al. “Pediatric lung adenocarcinoma presenting with brain metastasis: a case report.” Journal of medical case reports vol. 12,1 243. 2 Sep. 2018, doi:10.1186/s13256-018-1781-1
Ladanyi, Marc, et al. "Pediatric Non-Small Cell Lung Cancer." NORD, 11 July 2019, rarediseases.org/rare-diseases/pediatric-non-small-cell-lung-cancer/.
Schulman, Jill Seladi. "Can Kids Get Lung Cancer?" healthline, 31 Mar. 2022, www.healthline.com/health/cancer/can-kids-get-lung-cancer.
Sherrell, Zia. "What to know about pediatric non-small cell lung cancer." Medical News Today, 30 Nov. 2021, www.medicalnewstoday.com/articles/pediatric-non-small-cell-lung-cancer.
Comments